SM Sino Technology Investment reduces AprilBio stake from 6.99% to 5.41% through open market sales, maintaining simple investment purpose
SM Sino Technology Investment reduced its stake in AprilBio from 6.99% to 5.41% due to dissolution of special relationship reporting and open market sales.
The main seller was the fund 이베스트 시노신기술조합 제일호 which sold all 225,995 shares, with other related parties selling small amounts.
The filer maintains a simple investment purpose and has no intention to influence management.
This report reflects only open market sales of existing shares, with no capital changes or new issuances.
[AI Summary]The stake reduction by SM Sino Technology Investment is a portfolio adjustment under a simple investment purpose, without new fundraising or strategic changes. The impact on stock price is limited, and the stated purpose indicates low likelihood of a governance dispute.